If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 188.20
Bid: 188.20
Ask: 188.60
Change: 0.00 (0.00%)
Spread: 0.40 (0.213%)
Open: 185.80
High: 191.20
Low: 185.80
Prev. Close: 188.20
ESNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FY 2023 Pre-Close Trading Update

17 Jan 2024 07:00

RNS Number : 9101Z
Essentra plc
17 January 2024
 

ESSENTRA PLC

PRE-CLOSE TRADING UPDATE

A resilient Q4 performance, FY23 expectations unchanged

 

Essentra plc ("Essentra", the "Group", or the "Company"), a leading global provider of essential components and solutions, today provides a trading update for the thirteen weeks ended 31 December 2023 ("Q4").

The Group's FY23 expectations remain unchanged. The Group expects to deliver adjusted operating profit for the full year in line with previous guidance. The business continues to demonstrate operational and financial resilience, remaining well positioned to continue to progress towards its medium-term targets.

Trading update

In Q4, the Group saw a sequential improvement in performance compared to the previous quarter. Group revenue on a like-for-like1 ("LFL") and trading day adjusted basis declined -3.6% in Q4 2023, compared to the same period in the prior year, an improvement on the -7.1% decline reported in Q3 2023, as comparatives continued to ease after a strong H1 2022 performance.

EMEA saw an improvement in new order momentum in Q4, whilst continuing to experience market softening as previously guided, in line with changes to the macro-environment. The AMERS region saw trading stability quarter on quarter, and remains focused on the improvement in destocking trends within distributor end-market channels. The APAC business has continued to demonstrate a gradual recovery.

Through a combination of disciplined and proactive initiatives taken through 2023, including effective sales pricing offsetting inflation, Group adjusted operating margins remain strong. Central corporate costs, that were re-sized in H1 2023, continue to be well managed, and remain in line with previous guidance of approximately £13m.

The BMP TAPPI acquisition, completed on 26 October 2023 is performing in line with management expectations, early integration plans are on track.

Outlook

With a robust and differentiated business model, underpinned by its breadth of customers, end market categories and geographical diversification, Essentra is well positioned, and continues to demonstrate through-cycle financial resilience. The Group's balance sheet and cash generation remain strong, providing optionality for investment in organic growth initiatives and earnings enhancing M&A.

Through operational leverage, acquisition synergies and the compounding benefit of cost actions taken by management in 2023, the Group remains confident in delivering progress towards its medium-term targets.

 

Commenting on today's announcement, Scott Fawcett, Chief Executive Officer, said:

"I'm pleased with Essentra's performance in its first full year as a standalone components business. This year, we have been operationally successful whilst navigating the macro-economic backdrop, with the execution of M&A, the expansion of our footprint and right-sizing of our central cost base. We are on track to deliver adjusted operating profit in line with previously shared guidance, and continue to progress towards our medium-term targets".

Notice of results

Essentra will release its preliminary results for the twelve months ended 31 December 2023 on 19 March 2024. Further details regarding the Company's presentation to analysts and investors will be provided nearer the time.

 

1. The term "like-for-like" describes the performance of the continuing business on a comparable basis, adjusting for the impact of acquisitions, disposals and foreign exchange. 2023 LFL sales performance is adjusted for the acquisition of the Wixroyd Group ("Wixroyd") on 1 December 2022 and BMP s.r.l ("BMP TAPPI") on 26 October 2023.

 

 

 

Enquiries

Essentra plc

FTI Consulting

Jack Clarke, Chief Financial Officer

Richard Mountain

Claire Goodman, Investor Relations Manager

Emma Reid, Company Secretary

Ariadna Peretz

FTI_essentra@fticonsulting.com

Tel: +44 (0)1908 359100

Tel: +44 (0)20 3727 1340

 

Notes to Editors

About Essentra plc

Essentra plc is a FTSE 250 company and a leading global provider of essential components and solutions, focusing on the manufacture and distribution of plastic injection moulded, vinyl dip moulded and metal items.

Headquartered in the United Kingdom, Essentra's global network extends to 28 countries worldwide and includes over 3,000 employees, 13 manufacturing facilities, 24 distribution centres and 33 sales & service centres serving c.74,000 customers with a rapid supply of low cost but essential products for a variety of applications in industries such as equipment manufacturing, automotive, fabrication, electronics, medical and renewable energy.

For further information, please visit www.essentraplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSTLIIRLIS
Date   Source Headline
26th Apr 202210:42 amRNSHolding(s) in Company
21st Apr 202211:57 amRNSHolding(s) in Company
11th Apr 20224:00 pmRNSAnnual Report and Accounts and Notice of AGM
4th Apr 20224:17 pmRNSHolding(s) in Company
4th Apr 20229:55 amRNSDirectorate Change
1st Apr 20229:25 amRNSTotal Voting Rights
18th Mar 20227:00 amRNSResults for the Full Year Ended 31 December 2021
14th Mar 20227:00 amRNSDirectorate Change
4th Mar 202211:00 amRNSInvitation to FY 2021 Results Presentation
1st Mar 20229:52 amRNSTotal Voting Rights
8th Feb 202212:00 pmRNSNotice of Results
1st Feb 20229:02 amRNSTotal Voting Rights
7th Jan 20227:00 amRNSFY 2021 Pre-close trading update
4th Jan 20227:58 amRNSTotal Voting Rights
20th Dec 202111:13 amRNSResult of AGM
17th Dec 20217:46 amRNSTotal Voting Rights
26th Nov 20217:00 amRNSStrategic Update and Directorate Change
22nd Nov 202110:32 amRNSHolding(s) in Company
3rd Nov 20217:00 amRNSTotal Voting Rights
26th Oct 20217:00 amRNSStrategic Update and Q3 2021 Trading
1st Oct 20218:13 amRNSTotal Voting Rights
2nd Sep 202111:36 amRNSTotal Voting Rights
13th Aug 20217:00 amRNSAppointment of Board Trainee
3rd Aug 20217:00 amRNSCompletion of Components Acquisition in China
2nd Aug 20217:00 amRNSTotal Voting Rights
30th Jul 20217:00 amRNSResults for the Half Year Ended 30 June 2021
20th Jul 202112:00 pmRNSInvitation to HY 2021 Results Presentation
7th Jul 20217:00 amRNSHY 2021 Pre-Close Trading Update
1st Jul 20217:50 amRNSChange of Registered Office
1st Jul 20217:48 amRNSTotal Voting Rights
28th Jun 20214:02 pmRNSDirectorate Change
25th Jun 20215:01 pmRNSAppointment of a Non-Executive Director
2nd Jun 20218:25 amRNSTotal Voting Rights
28th May 20213:38 pmRNSHolding(s) in Company
20th May 202112:30 pmRNSResult of AGM
20th May 20217:00 amRNSAGM 2021 Trading Update
18th May 20217:25 amRNSDirector Declaration
13th May 20217:00 amRNSComponents Acquisition in China
4th May 202111:21 amRNSTotal Voting Rights
21st Apr 20217:00 amRNSHolding(s) in Company
16th Apr 20217:00 amRNS1st Quarter Results
9th Apr 202111:00 amRNSForthcoming Q1 2021 Trading Update
1st Apr 20214:17 pmRNSDirector/PDMR Shareholding - Replacement
1st Apr 20213:59 pmRNSDirector/PDMR Shareholding
1st Apr 20213:56 pmRNSDirector/PDMR Shareholding
1st Apr 20213:54 pmRNSDirector/PDMR Shareholding
1st Apr 202110:10 amRNSTotal Voting Rights
30th Mar 20212:53 pmRNSDirector/PDMR Shareholding
30th Mar 202112:24 pmRNSDirector/PDMR Shareholding
10th Mar 20213:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.